Based on recent data, Nuvation Bio Inc. (NUVB) shows an Average True Range (ATR) of 0.38 and an Enterprise Value of 541.36M. Its average trading volume over the past 3 months is 6.66M, indicating liquidity. These fundamental metrics provide insight into NUVB's underlying financial health and market activity.
| ATR | 0.38 |
| Enterprise Value | 541.36M |
| Avg Vol (3 Months) | 6.66M |
| Avg Vol (10 Days) | 4.29M |
Nuvation Bio Inc. (NUVB) technical indicators as of September 4, 2026: the SMA 20 is 2.7%, SMA 50 at -15.75%, and SMA 200 at 31.94%. The RSI 14 value is 46.78, suggesting its current momentum. These technical analysis signals help assess NUVB's price trends and potential future movements.
| SMA 20 | 2.7% |
| SMA 50 | -15.75% |
| SMA 200 | 31.94% |
| RSI 14 | 46.78 |
Nuvation Bio Inc. (NUVB) stock performance overview as of September 4, 2026: The 52-week high is $9.75 (currently -40.51% below), and the 52-week low is $2.99 (currently 276.62% above). Over the past year, NUVB's performance is 136.61%, compared to the S&P 500's 1.58% change.
| 52-Week High | 9.75 |
| 52-Week High Chg | -40.51% |
| 52-Week Low | 2.99 |
| 52-Week Low Chg | +276.62% |
| S&P 500 52-Week Chg | 1.58% |
According to market data, Nuvation Bio Inc. (NUVB) stock's recent performance metrics show that over the last month, NUVB is -29.46%, with a Year-to-Date (YTD) performance of -32.92%. Over the past year, the stock has seen a 136.61% change. These figures summarize NUVB's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 7.13 | 7.58 | 7.58 | 7.58 | 9.75 | 9.1 |
| Low | 6.49 | 5.88 | 4.45 | 4.05 | 2.99 | 4.05 |
| Performance | -6.97% | -29.46% | +76.25% | +155.74% | +136.61% | -32.92% |
According to current financial data, NUVB stock's P/E (TTM) ratio is -15.71, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for NUVB, including P/S (13.95), P/B (9.38), and P/FCF (-28.65), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | NUVB | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -15.71 | -1.25 | -194.36 | 32.59 |
| P/S (TTM) | 13.95 | 3.71 | 467.56 | 5.98 |
| P/B (TTM) | 9.38 | 0.85 | 16.39 | 5.77 |
| P/FCF (TTM) | -28.65 | -1.96 | -754.77 | 29.62 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep